"Causes of Angelman Syndrome: Understanding This Rare Genetic Condition"
Angelman syndrome (AS) is a rare, severe neurological disorder that affects many aspects of a person’s life, including physical, cognitive, and behavioral abilities. It's caused by a loss of function of the UBE3A gene, which provides instructions for making an enzyme called E6-AP. This gene is part of the ubiquitin pathway, responsible for targeted protein degradation in cells. So, what causes Angelman syndrome, and how does this gene defect manifest into such a complex condition?
Understanding the cause of Angelman syndrome requires delving into the intricacies of genetics, specifically the phenomenon of imprinting. Imprinting involves a process where certain genes are expressed from only one parent's copy. The UBE3A gene is a good example; in most parts of the body, UBE3A is expressed only from the mother's copy, and the father's copy is silenced. This phenomenon sets the stage for different scenarios leading to Angelman syndrome.
Causes of Angelman Syndrome
The loss of UBE3A function can occur in several ways, all leading to the characteristic features of Angelman syndrome. Understanding these causes, outlined below, can help families, caregivers, and researchers better cope with and address the condition.
These causes can be categorized into three main groups: Deletions, Uniparental Disomy (UPD), and Mutations, each with their respective sub-topics making up the various forms Angelman syndrome can take.
Deletions
Deletions account for about 70% of AS cases. They occur when a piece of DNA, containing the UBE3A gene, is missing from the maternal chromosome 15. This deletion leads to a lack of functional protein, E6-AP, needed for normal neuron function, causing Angelman syndrome symptoms.
There are different types of deletions, including classic, atypical, and small intragenic deletions. The classic deletion is the largest, while the other types can be harder to detect.
Uniparental Disomy (UPD)
UPD happens when both copies of chromosome 15 come from the father instead of one from each parent. Normally, one copy of each Chromosome comes from the mother and the other from the father. In UPD, the maternal copy of UBE3A is replaced by a non-functioning paternal copy, resulting in AS.
UPD accounts for around 2-3% of Angelman syndrome cases and can be further divided into isodisomy and heterodisomy, depending on whether the two copies of chromosome 15 are exact replicas or not.
Other Causes & Correlations
While the above causes relate directly to the UBE3A gene and its function, there are other correlations that contribute to the development and presentation of Angelman syndrome.
The correlation between Angelman syndrome and autism spectrum disorder (ASD) is one such indirect relationship. Research suggests that around 15% of individuals with AS also have autism, and both disorders share some symptoms, although the reasons for this connection remain uncertain.
Maternal UBE3A Epimutations
Epimutations are changes in gene expression, not in the actual DNA sequence. In Angelman syndrome, maternal epimutations involve a phenomenon called DNA methylation, which suppresses the maternal UBE3A allele. As a result, the normal maternal UBE3A copy is not expressed, leading to AS symptoms.
These epimutations account for around 2-3% of AS cases and are more commonly seen in individuals with a Clinical Diagnostics Test but a negative genetic test result.
Paternal UBE3A Mutations
In rare cases, Angelman syndrome results from a point mutation (a single letter change in the DNA) in the UBE3A gene. These mutations occur in the paternal copy of the gene, which would typically be inactive due to imprinting. However, when a mutation occurs, the paternal copy may become active, leading to Angelman syndrome.
These mutations are uncommon, accounting for about 3-5% of AS cases, and may present differently than the other forms of the disorder.
Research is ongoing to understand the complex interactions of these causes and correlations better, providing avenues for future therapeutics and improving the lives of individuals with Angelman syndrome and their families.